Polymyxin B Inactivation of Lipopolysaccharide in Vaccines of Gram-Negative Bacteria
- 1 July 1981
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 33 (1) , 315-318
- https://doi.org/10.1128/iai.33.1.315-318.1981
Abstract
Endotoxin activity in suspensions of Bordetella pertussis, Escherichia coli, Haemophilus influenzae, and Pseudomonas aeruginosa was often markedly decreased by polymyxin B. Polymyxin B treatment may be a means to reduce inflammatory reactivity of lipopolysaccharide in vaccines of gram-negative bacteria.This publication has 28 references indexed in Scilit:
- Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharidesPublished by Elsevier ,2003
- Characterization of Lipopolysaccharide of Haemophilus influenzaeThe Journal of Infectious Diseases, 1978
- Polymyxin and Related Peptide AntibioticsAnnual Review of Biochemistry, 1977
- Association between mitogenicity and immunogenicity of 4-hydroxy-3,5-dinitrophenacetyl-lipopolysaccharide, a T-independent antigen.The Journal of Experimental Medicine, 1976
- Dissociation between mitogenicity and immunogenicity of TNP- lipopolysaccharide, a T-independent antigenThe Journal of Experimental Medicine, 1975
- Degradation of phospholipid in Pseudomonas aeruginosa induced by polymyxin B.The Journal of Antibiotics, 1975
- Inactivation of Endotoxin by Polymyxin BAntimicrobial Agents and Chemotherapy, 1974
- Neuromuscular Blocking Properties of Various Polypeptide Antibiotics.Experimental Biology and Medicine, 1960
- THE RELEASE OF HISTAMINE BY POLYMYXIN B AND POLYMYXIN EBritish Journal of Pharmacology and Chemotherapy, 1955
- The interaction of polymyxin E with bacterial and other lipidsBiochimica et Biophysica Acta, 1955